Impact of stimulant medication on eating control in youth with ADHD
Effect of Stimulant Medication on Loss of Control Eating in Youth With Attention Deficit/Hyperactivity Disorder: a Prospective, Observational Case Series
This study is testing if stimulant medication can help kids with ADHD who struggle with losing control over their eating habits.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10 (estimated) |
| Ages | 8 Years to 13 Years |
| Sex | All |
| Sponsor | Nova Scotia Health Authority Academic / other |
| Locations | 1 site (Halifax, Nova Scotia) |
| Trial ID | NCT05592119 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the relationship between stimulant medication and loss of control eating (LOC-E) in youth diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD). It will involve a cohort of children aged 8 to 13 years who have experienced episodes of LOC-E, with data collected from various clinics in Nova Scotia. The study will assess neurocognitive factors associated with LOC-E and explore whether stimulant treatment can mitigate these symptoms. The research team will utilize standardized assessments to evaluate the participants' eating behaviors and ADHD symptoms over time.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 8 to 13 years who have been diagnosed with ADHD and have experienced episodes of loss of control eating.
Not a fit: Patients currently receiving treatment for overweight or those taking medications that affect eating behavior may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for youth with ADHD who experience loss of control eating, potentially preventing the development of more severe eating disorders.
How similar studies have performed: While stimulant medications have shown promise in treating impulsivity and binge eating in adults, this specific approach in youth with ADHD and LOC-E is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Youth 8 to 13 years of age * Able to provide informed consent * Meet DSM-V diagnostic criteria for ADHD * Experienced at least 3 episodes of LOC-E during the past 3 months, accompanied by some degree of distress and 2 of the 5 behavioural symptoms associated with LOC-E Exclusion Criteria: * Currently receiving treatment for overweight * Taking medication with effects on eating behaviour * Insufficient English language skills
Where this trial is running
Halifax, Nova Scotia
- Abbie J Lane Memorial Building - QEII — Halifax, Nova Scotia, Canada (Recruiting)
Study contacts
- Principal investigator: Aaron R Keshen, MD, FRCPC — Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia
- Study coordinator: Aaron R Keshen, MD, FRCPC
- Email: aaron.keshen@nshealth.ca
- Phone: (902) 473-6288
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.